drugset / Trial / NCT05980156

Comparing Chemoprevention Drugs for School-based Malaria Control

NCT05980156

RandomizedParallel-groupSingle-blindPrevention

Summary

This is an individually randomized, controlled, single blind three arm clinical trial of malaria chemoprevention strategies Arm 1: Intermittent preventive treatment with dihydroartemisinin-piperaquine (IPT-DP). Arm 2: Intermittent preventive treatment with sulfadoxine-pyrimethamine (SP) plus chloroquine (CQ) (IPT-SPCQ). Arm 3: Control - students will receive standard of care (no preventive treatment). Outcomes include P. falciparum infection and parasite density, anemia, cognitive function and educational testing, as well as infection prevalence in young children sleeping student's households to assess the impact on transmission.

Timeline

Start
2023-02-13
Primary completion
2023-07-28
Completion
2023-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule
Subject Dihydroartemisinin-piperaquine Unknown
Subject Sulfadoxine-pyrimethamine Small molecule